[go: up one dir, main page]

GB202301959D0 - Antibodies - Google Patents

Antibodies

Info

Publication number
GB202301959D0
GB202301959D0 GBGB2301959.9A GB202301959A GB202301959D0 GB 202301959 D0 GB202301959 D0 GB 202301959D0 GB 202301959 A GB202301959 A GB 202301959A GB 202301959 D0 GB202301959 D0 GB 202301959D0
Authority
GB
United Kingdom
Prior art keywords
antibodies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2301959.9A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oxford University Innovation Ltd
Original Assignee
Oxford University Innovation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oxford University Innovation Ltd filed Critical Oxford University Innovation Ltd
Priority to GBGB2301959.9A priority Critical patent/GB202301959D0/en
Priority to TW112105633A priority patent/TW202342510A/en
Priority to SM20250056T priority patent/SMT202500056T1/en
Priority to MA61946A priority patent/MA61946B1/en
Priority to HRP20250103TT priority patent/HRP20250103T1/en
Priority to FIEP23157409.6T priority patent/FI4230650T3/en
Priority to CR20240389A priority patent/CR20240389A/en
Priority to CN202380034355.XA priority patent/CN119403828B/en
Priority to PT231574096T priority patent/PT4230650T/en
Priority to EP23707291.3A priority patent/EP4479425A1/en
Priority to LTEP23157409.6T priority patent/LT4230650T/en
Priority to ARP230100391A priority patent/AR128564A1/en
Priority to ES23157409T priority patent/ES3012638T3/en
Priority to JP2024548670A priority patent/JP2025507595A/en
Priority to AU2023220851A priority patent/AU2023220851A1/en
Priority to IL315020A priority patent/IL315020A/en
Priority to KR1020247030884A priority patent/KR20240142594A/en
Priority to EP23157409.6A priority patent/EP4230650B1/en
Priority to HUE23157409A priority patent/HUE070285T2/en
Priority to US18/171,216 priority patent/US12030927B2/en
Priority to US18/839,067 priority patent/US20250154231A1/en
Priority to SI202330017T priority patent/SI4230650T1/en
Priority to CA3252608A priority patent/CA3252608A1/en
Priority to DK23157409.6T priority patent/DK4230650T3/en
Priority to RS20250121A priority patent/RS66591B1/en
Priority to PL23157409.6T priority patent/PL4230650T3/en
Priority to GB2305426.5A priority patent/GB2614651B/en
Priority to PCT/EP2023/054109 priority patent/WO2023156636A1/en
Publication of GB202301959D0 publication Critical patent/GB202301959D0/en
Priority to US18/664,079 priority patent/US20240376178A1/en
Priority to CL2024002462A priority patent/CL2024002462A1/en
Priority to MX2024010178A priority patent/MX2024010178A/en
Priority to CONC2024/0012622A priority patent/CO2024012622A2/en
Ceased legal-status Critical Current

Links

GBGB2301959.9A 2022-02-18 2023-02-10 Antibodies Ceased GB202301959D0 (en)

Priority Applications (32)

Application Number Priority Date Filing Date Title
GBGB2301959.9A GB202301959D0 (en) 2023-02-10 2023-02-10 Antibodies
TW112105633A TW202342510A (en) 2022-02-18 2023-02-16 Antibodies
IL315020A IL315020A (en) 2022-02-18 2023-02-17 Antibodies capable of binding to the spike protein of coronavirus sars-cov-2
KR1020247030884A KR20240142594A (en) 2022-02-18 2023-02-17 Antibodies that can bind to the spike protein of the coronavirus SARS-COV-2
HRP20250103TT HRP20250103T1 (en) 2022-02-18 2023-02-17 ANTIBODIES THAT CAN BINDE TO THE SPIKE PROTEIN OF THE SARS-COV-2 CORONAVIRUS
FIEP23157409.6T FI4230650T3 (en) 2022-02-18 2023-02-17 Antibodies capable of binding to the spike protein of coronavirus sars-cov-2
CR20240389A CR20240389A (en) 2022-02-18 2023-02-17 Antibodies capable of binding to the spike protein of coronavirus sars-cov-2
CN202380034355.XA CN119403828B (en) 2022-02-18 2023-02-17 Antibodies that can bind to the spike protein of the coronavirus SARS-CoV-2
PT231574096T PT4230650T (en) 2022-02-18 2023-02-17 Antibodies capable of binding to the spike protein of coronavirus sars-cov-2
EP23707291.3A EP4479425A1 (en) 2022-02-18 2023-02-17 Antibodies capable of binding to the spike protein of coronavirus sars-cov-2
HUE23157409A HUE070285T2 (en) 2022-02-18 2023-02-17 Antibodies capable of binding to the spike protein of coronavirus sars-cov-2
ARP230100391A AR128564A1 (en) 2022-02-18 2023-02-17 ANTIBODIES
ES23157409T ES3012638T3 (en) 2022-02-18 2023-02-17 Antibodies capable of binding to the spike protein of coronavirus sars-cov-2
JP2024548670A JP2025507595A (en) 2022-02-18 2023-02-17 Antibodies capable of binding to the spike protein of coronavirus SARS-CoV-2
AU2023220851A AU2023220851A1 (en) 2022-02-18 2023-02-17 Antibodies capable of binding to the spike protein of coronavirus sars-cov-2
SM20250056T SMT202500056T1 (en) 2022-02-18 2023-02-17 Antibodies capable of binding to the spike protein of coronavirus sars-cov-2
EP23157409.6A EP4230650B1 (en) 2022-02-18 2023-02-17 Antibodies capable of binding to the spike protein of coronavirus sars-cov-2
US18/171,216 US12030927B2 (en) 2022-02-18 2023-02-17 Antibodies capable of binding to the spike protein of coronavirus SARS-CoV-2
LTEP23157409.6T LT4230650T (en) 2022-02-18 2023-02-17 Antibodies capable of binding to the spike protein of coronavirus sars-cov-2
MA61946A MA61946B1 (en) 2022-02-18 2023-02-17 Antibodies capable of binding to the spike protein of coronavirus sars-cov-2
US18/839,067 US20250154231A1 (en) 2022-02-18 2023-02-17 Antibodies capable of binding to the spike protein of cononavirus sars-cov-2
SI202330017T SI4230650T1 (en) 2022-02-18 2023-02-17 Antibodies capable of binding to the spike protein of coronavirus sars-cov-2
CA3252608A CA3252608A1 (en) 2022-02-18 2023-02-17 Antibodies capable of binding to the spike protein of coronavirus sars-cov-2
DK23157409.6T DK4230650T3 (en) 2022-02-18 2023-02-17 ANTIBODIES ABLE TO BINDING TO THE SPIKE PROTEIN OF THE CORONAVIRUS SARS-COV-2
RS20250121A RS66591B1 (en) 2022-02-18 2023-02-17 ANTIBODIES CAPABLE OF BINDING TO THE SPIKE PROTEIN OF CORONAVIRUS SARS-COV-2
PL23157409.6T PL4230650T3 (en) 2022-02-18 2023-02-17 Antibodies capable of binding to the spike protein of coronavirus sars-cov-2
GB2305426.5A GB2614651B (en) 2022-02-18 2023-02-17 Antibodies
PCT/EP2023/054109 WO2023156636A1 (en) 2022-02-18 2023-02-17 Antibodies capable of binding to the spike protein of coronavirus sars-cov-2
US18/664,079 US20240376178A1 (en) 2022-02-18 2024-05-14 Antibodies capable of binding to the spike protein of cononavirus sars-cov-2
CL2024002462A CL2024002462A1 (en) 2022-02-18 2024-08-16 Antibodies capable of binding to the spike protein of coronavirus sars-cov-2
MX2024010178A MX2024010178A (en) 2022-02-18 2024-08-19 Antibodies capable of binding to the spike protein of coronavirus sars-cov-2
CONC2024/0012622A CO2024012622A2 (en) 2022-02-18 2024-09-17 Antibodies capable of binding to the spike protein of the coronavirus sars-cov-2

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2301959.9A GB202301959D0 (en) 2023-02-10 2023-02-10 Antibodies

Publications (1)

Publication Number Publication Date
GB202301959D0 true GB202301959D0 (en) 2023-03-29

Family

ID=85704478

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2301959.9A Ceased GB202301959D0 (en) 2022-02-18 2023-02-10 Antibodies

Country Status (1)

Country Link
GB (1) GB202301959D0 (en)

Similar Documents

Publication Publication Date Title
GB202014851D0 (en) SARS-COV-2 antibodies
GB2614651B (en) Antibodies
GB2627309B (en) Antibodies
IL317231A (en) Anti-bcma antibodies
GB202304512D0 (en) Antibodies
GB202217924D0 (en) Antibodies
GB202309981D0 (en) Antibody
GB202204159D0 (en) Antibodies
IL320725A (en) Anti-beta-catenin antibodies
GB202400120D0 (en) Anti-pgdh antibodies
GB202319255D0 (en) Anti-UNC5C antibodies
GB202318820D0 (en) Antibodies
GB202317371D0 (en) Anti-unc5c antibodies
GB202317192D0 (en) Anti-agr2 antibodies
GB202317189D0 (en) Anti-AGR2 antibodies
GB202317188D0 (en) Anti-AGR2 antibodies
GB202317187D0 (en) Anti-AGR2 antibodies
GB202316016D0 (en) Antibodies
GB202311473D0 (en) Anti-ifnl1/reg3a antibodies
GB202311470D0 (en) Anti-BST2 antibodies
GB202309920D0 (en) Antibodies
GB202308884D0 (en) Anti-fibril antibodies
GB202308898D0 (en) Anti-fibril antibodies
GB202306874D0 (en) Antibodies
GB202306051D0 (en) Antibodies

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)